兰州佛慈制药股份有限公司 2025年第三季度报告

Core Points - The company guarantees the authenticity, accuracy, and completeness of the information disclosed in the quarterly report, with no false records or misleading statements [2][6][11] Financial Data - The third-quarter financial report has not been audited [6] - The company does not require retrospective adjustments or restatements of previous accounting data [3] - There are no non-recurring profit and loss items applicable for the quarter [3] Board Meeting - The eighth board meeting of the company was held on October 28, 2025, with all six directors present [7] - The meeting approved the "2025 Third Quarter Report" [8] - The resolution was passed with a unanimous vote of 6 in favor, 0 against, and 0 abstentions [10]